Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 3, 2010, Pages 699-709

  Legostaeva, Galina A ^a   Polosukhina, Dar'ya I ^a   Bezuglova, Anna M ^a   Doronin, Boris M ^b   Buneva, Valentina N ^a   Nevinsky, Georgy A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Catalytic IgG; Human blood; Hydrolysis of myelin basic protein; Multiple sclerosis

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; PEPTIDE HYDROLASE;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ARTICLE; BIOCATALYSIS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROLYSIS; IMMUNOLOGY; KINETICS; MALE; METABOLISM; MIDDLE AGED; MULTIPLE SCLEROSIS; PH; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; AUTOANTIBODIES; BIOCATALYSIS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; IMMUNOGLOBULIN G; KINETICS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDE HYDROLASES; YOUNG ADULT;

EID: 77953486424     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00738.x     Document Type: Article

References (43)

1. Keinan EE. Catalytic antibodies. 2005, 1-586. Editor, Weinheim: Wiley-VCH Verlag GmbH and Co. KgaA, pp
2. Paul S, Volle DJ, Beach CM. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science. 1989, 244:1158-62.
3. Nevinsky GA, Buneva VN. Human catalytic RNA- and DNA-hydrolyzing antibodies. J Immunol Methods. 2002, 269:235-45.
4. Nevinsky GA, Favorova OO, Buneva VN. Natural catalytic antibodies - new characters in the protein repertoire: Protein-protein interactions: a molecular cloning manual. 2002, 523-34. Golemis E, In, editor, New York, Cold Spring Harbor: Cold Spring Harbor Lab. Press, pp
5. Nevinsky GA, Buneva VN. Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J Cell Mol Med. 2003, 7:265-76.
6. Nevinsky GA, Buneva VN. Natural catalytic antibodies-abzymes. Catalytic antibodies 2005, 503-67. Keinan E, In, editor, Weinheim: Wiley-VCH Verlag GmbH and Co. KgaA, pp
7. Shuster AM, Gololobov GV, Kvashuk OA. DNA hydrolyzing autoantibodies. Science. 1992, 256:665-7.
8. Kalaga R, Li L, O'Dell JR. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J Immunol. 1995, 155:2695-702.
9. Savel'ev AN, Eneyskaya EV, Shabalin KA. Autoantibodies with amylolytic activity. Prot Pept Lett. 1999, 6:179-84.
10. Izadyar LA, Friboulet MH, Remy A. Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity. Proc Natl Acad Sci USA. 1993, 90:8876-80.
11. Kolesnikov AV, Kozyr AV, Alexandrova ES. Enzyme mimicry by the antiidiotypic antibody approach. Proc Natl Acad Sci USA. 2000, 97:13526-31.
12. Paul S. Mechanism and functional role of antibody catalysis. Appl Biochem Biotechnol. 1998, 75:13-23.
13. Kozyr AV, Kolesnikov A, Aleksandrova ES. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol. 1998, 75:45-61.
14. Sinohara H, Matsuura K. Does catalytic activity of Bens-Jones proteins contribute to the pathogenesis of multiple myeloma. Appl Biochem Biotechnol. 2000, 83:85-94.
15. Nevinsky GA, Breusov AA, Baranovskii AG. Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter. Med Sci Monit. 2001, 7:201-11.
16. Lacroix-Desmazes S, Bayry J, Kaveri SV. High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci USA. 2005, 102:4109-13.
17. O'Connor KC, Bar-Or A, Hafler DA. Neuroimmunology of multiple sclerosis. J Clin Immunol. 2001, 21:81-92.
18. Archelos JJ, Storch MK, Hartung HP. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol. 2000, 47:694-706.
19. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci. 2002, 3:291-301.
20. Cross AH, Trotter JL, Lyons J. B cells and antibodies in CNS demyelinating disease. J Neuroimmunol. 2001, 112:1-14.
21. Williamson RA, Burgoon MP, Owens GP. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci USA. 2001, 98:1793-8.
22. Baranovskii AG, Kanyshkova TG, Mogelnitskii AS. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry. 1998, 63:1239-48.
23. Baranovskii AG, Ershova NA, Buneva VN. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett. 2001, 76:163-7.
24. Savel'iev AN, Ivanen DR, Kulminskaya AA. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol Lett. 2003, 86:291-7.
25. Vanguri P, Lee E, Henkart P. Hydrolysis of myelin basic protein in myelin membranes by granzymes of large granular lymphocytes. J Immunol. 1993, 150:2431-9.
26. Polosukhina DI, Kanyshkova TG, Doronin BM. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J Cell Mol Med. 2004, 8:359-68.
27. Polosukhina DI, Buneva VN, Doronin BM. Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. Med Sci Monit. 2005, 11:BR266-72.
28. Polosukhina DI, Buneva VN, Doronin BM. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Immunol Lett. 2006, 103:75-81.
29. Ponomarenko NA, Durova OM, Vorobiev II. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci USA. 2006, 103:281-6.
30. Belogurov AA, Kurkova IN, Friboulet A. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol. 2008, 180:1258-67.
31. Andrievskaya OA, Buneva VN, Naumov VA. Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med Sci Monit. 2000, 6:460-70.
32. Andrievskaya OA, Buneva VN, Baranovskii AG. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol Lett. 2002, 81:191-8.
33. Kuznetsova I, Orlovskaya IA, Buneva VN. Activation of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice by different metal ions. Biochim Biophys Acta. 2007, 1774:884-96.
34. Poser CM. The diagnosis of multiple sclerosis 1984, 3-13. New York, Thieme-Stratton, pp
35. Horl WH, Wanner C, Schollmer P. Proteinases in catabolism and malnutrition. JPEN J Parenter Enteral Nutr. 1987, 11:98S-103S.
36. Rao MB, Tanksale AM, Ghatge MS. Molecular and biotechnological aspects of microbial proteases. Microbiol Mol Biol Rev. 1998, 62:597-635.
37. Odintsova ES, Buneva VN, Nevinsky GA. Casein-hydrolyzing activity of sIgA antibodies from human milk. J Mol Recognit. 2005, 18:413-21.
38. Tyutyulkova S, Gao QS, Thompson A. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display. Biochim Biophys Acta. 1996, 1316:217-23.
39. Paul S, Li L, Kalaga R. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and V fragment. J Biol Chem. 1995, 270:15257-61.
40. Sun M, Paul S. Altered cleavage site preference of a proteolytic antibody light chain induced by denaturation. FEBS Lett 1997, 407:289-90.
41. Gololobov GV, Chernova EA, Schourov DV. Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc Natl Acad Sci USA. 1995, 92:254-7.
42. Tawfik DS, Chap R, Green BS. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?. Proc Natl Acad Sci USA. 1995, 92:2145-9.
43. Nishi Y. Evolution of catalytic antibody repertoire in autoimmune mice. J Immunol Methods. 2002, 269:213-33.